Customer Guest RE-KYC
please type the captcha code.
Register|Generate Password|Dos and Don'ts of Demat Account
For Login related queries e-mail: emkayassist@emkayglobal.com
"Attention Investors
1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. 6.Investor Charter 7.Disclosure of Complaints 8.COMPLAINTS / SCORES
.......... Issued in the interest of Investors"
Regenerate OTP
Please contact to emkayassist@emkayglobal.com
Please select Mobile No and Email Id for OTP
Customer Guest
Login | Register
Login | Register|Forgot password?
Intimation of fire accident at Lyfius Pharma Private Limited a wholly owned step down subsidiary of the Company.more...
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1 Name of Company Aurobind...more...
Aurobindo Pharma Limited has informed the Exchange regarding a press release dated April 26 2025 titled CuraTeQ Biologics s.r.o a wholly owned step-d...more...
Submission of Press Release that is being issue by Curateq Biologics s .r.o a wholly owned step down subsidiary of the Company in connection...more...
Aurobindo Pharma Limited announced that its wholly owned subsidiary Eugia Pharma Specialities Limited has received final approval from the U.S. Food ...more...
Aurobindo Pharma Limited has informed the Exchange regarding a press release dated April 23 2025 titled Eugia Pharma receives USFDA approval...more...
Submission of Press Release that is being issued in connection with the receipt of USFDA approval for Dasatinib Tablets by Eugia Pharma Specialities ...more...
As of March 2025 51.82% is owned by Promoters and 48.18% by Public. Among Promoters holding Indian Promoters holds 48.75% and Foreign Promot...more...
Aurobindo Pharma Limited has informed the Exchange regarding a press release dated April 12 2025 titled Aurobindo Pharma receives final ANDA approval...more...
Submission of press release on receipt of final ANDA approval for RivaroxavanTablets USP.more...
Aurobindo Pharma Limited has informed the Exchange about General Updatesmore...
Intimation of completion of US FDA inspection at Raleigh Plant North Carolina owned by Aurolife Pharma LLC a wholly owned stepdown subsidiar...more...
Aurobindo Pharma Limited has informed the Exchange regarding a press release dated April 09 2025 titled CuraTeQ Biologics completes a successful Phas...more...
Submission of press release being issued by the Company.more...
Intimation of receipt of Marketing authorisation by Curateq Biologics s.r.o a wholly owned step down subsidiary of the Company.more...
Aurobindo Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations 2018more...
Submission of Certificate under regulation 74 (5) of SEBI (DP) Regulations for the Quarter ended March 31 2025more...
Enter Stock
BOARD MEETINGS Company Name : Aadhar Housing Fin Date : 06-05-2025